Tight development timelines and accelerated approval pathways favor simple, cost-effective capsule formulations. Capsules are a common oral solid dosage form and are produced in a variety of shapes, ...

A more tamper-proof formulation of extended-release Oxycodone DETERx (Collegium Pharmaceutical Inc) could help to minimize abuse of the opioid drug. Topline results of a new study show that crushing ...

Formulation characteristics must be optimized, following device selection, to achieve the desired performance for the capsule loaded in the dry powder inhaler. Capsules used in dry powder inhalers ...

Lone Star has entered into a definitive agreement to acquire the Capsules and Health Ingredients division of Lonza Group. Lonza will retain a 40 percent equity position in the business.

COLORADO SPRINGS, CO--(Marketwired - Nov 30, 2015) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based formulation, announces the launch of ...

Cyclosporine has revolutionised the transplantation scene in the last 20 years by helping with immunosuppresion. Novartis have so far had the patent Cyclosporine has revolutionised the transplantation ...

Introduction: Different oral sustained-release (SR) formulations of tramadol have been introduced in pain treatment in order to prolong the dosage interval to improve convenience for the patient. The ...

Phase I study of imetelstat (GRN163L) in combination with paclitaxel (P) and bevacizumab (B) in patients (pts) with locally recurrent or metastatic breast cancer (MBC). Methods: In this randomized, ...

In the Phase 2a obesity study, GSBR-1290 demonstrated a clinically meaningful and statistically significant placebo-adjusted mean decrease in weight of 6.2% 1 (p<0.0001) at 12 weeks. At Week 12, 67% ...

IIIM functions under the Council of Scientific and Industrial Research (CSIR). The Indian Institute of Integrative Medicine (IIIM) here on Wednesday said it has developed a capsule formulation from ...

The Company has not disclosed a reason for the medication discontinuation, however in 2017, the FDA reported that olaparib capsules were being phased out of the US market. [UPDATE 9/6/18] Lynparza ...